Abstract
A low count of CD4+ and CD8+ lymphocytes is a hallmark laboratory finding in the coronavirus disease 2019 (COVID-19). Using flow cytometry, we observed significantly higher CD95 (Fas) and PD-1 expression on both CD4+ T and CD8+ T cells in 42 COVID-19 patients when compared to controls. Higher CD95 expression in CD4+ cells correlated with lower CD4+ counts. A higher expression of CD95 in CD4+ and CD8+ lymphocytes correlated with a lower percentage of naive events. Our results might suggest a shift to antigen-activated T cells, expressing molecules increasing their propensity to apoptosis and exhaustion during COVID-19 infection.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 207-211 |
| Numero di pagine | 5 |
| Rivista | British Journal of Haematology |
| Volume | 191 |
| Numero di pubblicazione | 2 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2020 |
All Science Journal Classification (ASJC) codes
- Ematologia
Keywords
- 80 and over
- Adult
- Aged
- Aging
- Apoptosis
- CD4-Positive T-Lymphocytes
- CD8-Positive T-Lymphocytes
- CD95 (Fas)
- COVID-19
- Female
- Humans
- Lymphocyte Count
- Lymphocyte Subsets
- Lymphopenia
- Male
- Middle Aged
- PD-1
- Prognosis
- Programmed Cell Death 1 Receptor
- SARS-CoV-2
- apoptosis
- exhaustion
- fas Receptor
Fingerprint
Entra nei temi di ricerca di 'Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver